Preclinical services in Neurovascular diseases and Stroke

Transform your stroke-targeting innovations into therapeutic success: Work with STROK@LLIANCE, highly experienced team of experts since 2017.

• Our in vitro offer: in vitro tests on human blood and neuronal cultures to identify your lead compounds (neuroprotective, thrombolytic, anticoagulant, hemostatic, and antidote candidates ) and support their mechanism of action. Neuroprotective screening, Fibrinolysis and hemostasis screening, Pharmacological interaction and hemostasis.

• In vivo offer: a wide range of translational models (from small to large animals, efficacy pharmacology and non‑GLP safety) for efficacy, bleeding risk assessment, drug interactions, blood coagulation, fibrinolytics and thrombolytics, neuroprotection and functional recovery…

• A state-of-the-art environment to ensure robust, high-quality, and repeatable results: bioanalytical services (ELISA, WB, multiplexed assays, IHC) and high‑performance imaging (MRI, PET-Scan, MPI, echocardiography, fUS, HCS).